BlackRock Group’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$241K Buy
12,313
+1,344
+12% +$24.4K ﹤0.01% 2611
2016
Q3
$174K Buy
10,969
+576
+6% +$8.86K ﹤0.01% 2673
2016
Q2
$147K Sell
10,393
-193
-2% -$2.94K ﹤0.01% 2672
2016
Q1
$178K Buy
10,586
+7,764
+275% +$137K ﹤0.01% 2609
2015
Q4
$63K Sell
2,822
-77,840
-97% -$1.6M ﹤0.01% 2787
2015
Q3
$1.77M Sell
80,662
-103,278
-56% -$2.58M ﹤0.01% 1572
2015
Q2
$4.53M Buy
183,940
+1,900
+1% +$42.4K ﹤0.01% 1170
2015
Q1
$3.73M Hold
182,040
﹤0.01% 1224
2014
Q4
$3.63M Hold
182,040
﹤0.01% 1229
2014
Q3
$2.68M Hold
182,040
﹤0.01% 1306
2014
Q2
$3.35M Buy
182,040
+6,300
+4% +$105K ﹤0.01% 1268
2014
Q1
$3.31M Buy
+175,740
New +$3.6M ﹤0.01% 1289
2013
Q4
Sell
-745
Closed -$8K 2670
2013
Q3
$8K Buy
+745
New +$7.34K ﹤0.01% 2849

Other funds holding ATRC

BlackRock Group's ATRC Position: Q4 2016 in Review

BlackRock Group increased its AtriCure (ATRC) stake by 12% in Q4 2016, buying an estimated $24.4K and bringing the position to 12,313 shares worth $241K. The position accounts for ﹤0.01% of the portfolio, ranked #2611.

BlackRock Group first reported a position in ATRC in Q3 2013 and has held it in 13 quarters since. The position peaked at $4.53M in Q2 2015. 100 funds tracked by Wall St. Rank hold ATRC as of Q4 2016.

  • BlackRock Group held 12,313 shares of AtriCure worth $241K as of Q4 2016.
  • BlackRock Group bought 1,344 AtriCure shares in Q4 2016, an estimated $24.4K.
  • AtriCure made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2611 holding.
  • BlackRock Group first reported a position in AtriCure in Q3 2013 and has held it in 13 quarters since.
  • BlackRock Group's AtriCure position peaked at $4.53M in Q2 2015.
  • 100 funds tracked by Wall St. Rank held AtriCure as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.